International myeloma working group consensus recommendations on imaging in monoclonal plasma cell disorders
Hillengass, Jens, Usmani, Saad, Rajkumar, S Vincent, Durie, Brian G M, Mateos, María-Victoria, Lonial, Sagar, Joao, Cristina, Anderson, Kenneth C, García-Sanz, Ramón, Riva, Eloísa, Du, Juan, van de Donk, Niels, Berdeja, Jesús G, Terpos, Evangelos, Zamagni, Elena, Kyle, Robert A, San Miguel, Jesús, Goldschmidt, Hartmut, Giralt, Sergio, Kumar, Shaji, Raje, Noopur, Ludwig, Heinz, Ocio, Enrique, Schots, Rik, Einsele, Hermann, Schjesvold, Fredrik, Chen, Wen-Ming, Abildgaard, Niels, Lipe, Brea C, Dytfeld, Dominik, Wirk, Baldeep Mona, Drake, Matthew, Cavo, Michele, Lahuerta, Juan José, Lentzsch, Suzanne
Published in The lancet oncology (01.06.2019)
Published in The lancet oncology (01.06.2019)
Get full text
Journal Article
Idecabtagene vicleucel for relapsed and refractory multiple myeloma: post hoc 18-month follow-up of a phase 1 trial
Lin, Yi, Raje, Noopur S, Berdeja, Jesús G, Siegel, David S, Jagannath, Sundar, Madduri, Deepu, Liedtke, Michaela, Rosenblatt, Jacalyn, Maus, Marcela V, Massaro, Monica, Petrocca, Fabio, Yeri, Ashish, Finney, Olivia, Caia, Andrea, Yang, Zhihong, Martin, Nathan, Campbell, Timothy B, Rytlewski, Julie, Fuller, Jaymes, Hege, Kristen, Munshi, Nikhil C, Kochenderfer, James N
Published in Nature medicine (01.09.2023)
Published in Nature medicine (01.09.2023)
Get full text
Journal Article
First-in-Human Phase I Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients with Relapsed and Refractory Multiple Myeloma
Vij, Ravi, Nath, Rajneesh, Afar, Daniel E H, Mateos, María-Victoria, Berdeja, Jesús G, Raab, Marc S, Guenther, Andreas, Martínez-López, Joaquín, Jakubowiak, Andrzej J, Leleu, Xavier, Weisel, Katja, Wong, Shekman, Gulbranson, Scott, Sheridan, James P, Reddy, Anita, Paiva, Bruno, Singhal, Anil, San-Miguel, Jesús F, Moreau, Philippe
Published in Clinical cancer research (15.05.2020)
Published in Clinical cancer research (15.05.2020)
Get full text
Journal Article
Time-Dependent Prognostic Value of Serological and Measurable Residual Disease Assessments after Idecabtagene Vicleucel
Paiva, Bruno, Manrique, Irene, Rytlewski, Julie, Campbell, Timothy, Kazanecki, Christian C, Martin, Nathan, Anderson, Jr, Larry D, Berdeja, Jesús G, Lonial, Sagar, Raje, Noopur S, Lin, Yi, Moreau, Philippe, San-Miguel, Jesús F, Munshi, Nikhil C, Kaiser, Shari M
Published in Blood cancer discovery (01.09.2023)
Published in Blood cancer discovery (01.09.2023)
Get full text
Journal Article
Systemic Interleukin-2 and Adoptive Transfer of Lymphokine-Activated Killer Cells Improves Antibody-Dependent Cellular Cytotoxicity in Patients with Relapsed B-Cell Lymphoma Treated with Rituximab
Berdeja, Jesús G, Hess, Allan, Lucas, David M, O'Donnell, Paul, Ambinder, Richard F, Diehl, Louis F, Carter-Brookins, Denise, Newton, Susan, Flinn, Ian W
Published in Clinical cancer research (15.04.2007)
Published in Clinical cancer research (15.04.2007)
Get full text
Journal Article
The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia
Stein, Eytan M., Garcia-Manero, Guillermo, Rizzieri, David A., Tibes, Raoul, Berdeja, Jesus G., Savona, Michael R., Jongen-Lavrenic, Mojca, Altman, Jessica K., Thomson, Blythe, Blakemore, Stephen J., Daigle, Scott R., Waters, Nigel J., Suttle, A. Benjamin, Clawson, Alicia, Pollock, Roy, Krivtsov, Andrei, Armstrong, Scott A., DiMartino, Jorge, Hedrick, Eric, Löwenberg, Bob, Tallman, Martin S.
Published in Blood (14.06.2018)
Published in Blood (14.06.2018)
Get full text
Journal Article
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study
Kumar, Shaji K, Prof, Berdeja, Jesus G, MD, Niesvizky, Ruben, Prof, Lonial, Sagar, Prof, Laubach, Jacob P, MD, Hamadani, Mehdi, MD, Stewart, A Keith, Prof, Hari, Parameswaran, Prof, Roy, Vivek, MD, Vescio, Robert, MD, Kaufman, Jonathan L, MD, Berg, Deborah, MSN, Liao, Eileen, PhD, Di Bacco, Alessandra, PhD, Estevam, Jose, BSc, Gupta, Neeraj, PhD, Hui, Ai-Min, MD, Rajkumar, Vincent, Prof, Richardson, Paul G, Prof
Published in The lancet oncology (01.12.2014)
Published in The lancet oncology (01.12.2014)
Get full text
Journal Article
Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial
Younes, Anas, Dr, Berdeja, Jesus G, MD, Patel, Manish R, MD, Flinn, Ian, MD, Gerecitano, John F, MD, Neelapu, Sattva S, MD, Kelly, Kevin R, MD, Copeland, Amanda R, MSN, Akins, Amy, BSN, Clancy, Myles S, MBA, Gong, Lucy, PharmD, Wang, Jing, PhD, Ma, Anna, MS, Viner, Jaye L, MD, Oki, Yasuhiro, MD
Published in The lancet oncology (01.05.2016)
Published in The lancet oncology (01.05.2016)
Get full text
Journal Article
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial
Yee, Andrew J, MD, Bensinger, William I, MD, Supko, Jeffrey G, PhD, Voorhees, Peter M, MD, Berdeja, Jesus G, MD, Richardson, Paul G, Prof, Libby, Edward N, MD, Wallace, Ellen E, BA, Birrer, Nicole E, BA, Burke, Jill N, MSN, Tamang, David L, PhD, Yang, Min, PhD, Jones, Simon S, PhD, Wheeler, Catherine A, MD, Markelewicz, Robert J, MD, Raje, Noopur S, Dr
Published in The lancet oncology (01.11.2016)
Published in The lancet oncology (01.11.2016)
Get full text
Journal Article
Adjusted comparison of outcomes between patients from CARTITUDE-1 versus multiple myeloma patients with prior exposure to proteasome inhibitors, immunomodulatory drugs and anti-CD38 antibody from the prospective, multinational LocoMMotion study of real-world clinical practice
Mateos, Maria-Victoria, Weisel, Katja, Martin, Thomas, Berdeja, Jesús G, Jakubowiak, Andrzej, Stewart, A Keith, Jagannath, Sundar, Lin, Yi, Diels, Joris, Ghilotti, Francesca, Thilakarathne, Pushpike, Perualila, Nolen J, Cabrieto, Jedelyn, Haefliger, Benjamin, Erler-Yates, Nichola, Hague, Clare, Jackson, Carolyn C, Schecter, Jordan M, Strulev, Vadim, Nesheiwat, Tonia, Pacaud, Lida, Einsele, Hermann, Moreau, Philippe
Published in Haematologica (Roma) (01.08.2023)
Published in Haematologica (Roma) (01.08.2023)
Get full text
Journal Article
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials
Gavriatopoulou, Maria, Chari, Ajai, Chen, Christine, Bahlis, Nizar, Vogl, Dan T, Jakubowiak, Andrzej, Dingli, David, Cornell, Robert F, Hofmeister, Craig C, Siegel, David, Berdeja, Jesus G, Reece, Donna, White, Darrell, Lentzsch, Suzanne, Gasparetto, Cristina, Huff, Carol Ann, Jagannath, Sundar, Baz, Rachid, Nooka, Ajay K, Richter, Joshua, Abonour, Rafat, Parker, Terri L, Yee, Andrew J, Moreau, Philippe, Lonial, Sagar, Tuchman, Sascha, Weisel, Katja C, Mohty, Mohamad, Choquet, Sylvain, Unger, T J, Li, Kai, Chai, Yi, Li, Lingling, Shah, Jatin, Shacham, Sharon, Kauffman, Michael G, Dimopoulos, Meletios Athanasios
Published in Leukemia (01.09.2020)
Published in Leukemia (01.09.2020)
Get full text
Journal Article
Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma
Rowinsky, Eric K., Paner, Agne, Berdeja, Jesus G., Paba-Prada, Claudia, Venugopal, Parameswaran, Porkka, Kimmo, Gullbo, Joachim, Linder, Stig, Loskog, Angelica, Richardson, Paul G., Landgren, Ola
Published in Investigational new drugs (01.10.2020)
Published in Investigational new drugs (01.10.2020)
Get full text
Journal Article
Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance
Kumar, Shaji K, Berdeja, Jesus G, Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P, Hamadani, Mehdi, Stewart, A Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L, Berg, Deborah, Liao, Eileen, Rajkumar, S Vincent, Richardson, Paul G
Published in Leukemia (01.07.2019)
Published in Leukemia (01.07.2019)
Get full text
Journal Article
CHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma
Berenson, James R., Cartmell, Alan, Bessudo, Alberto, Lyons, Roger M., Harb, Wael, Tzachanis, Dimitrios, Agajanian, Richy, Boccia, Ralph, Coleman, Morton, Moss, Robert A., Rifkin, Robert M., Patel, Priti, Dixon, Sandra, Ou, Ying, Anderl, Janet, Aggarwal, Sanjay, Berdeja, Jesus G.
Published in Blood (30.06.2016)
Published in Blood (30.06.2016)
Get full text
Journal Article
Randomized Open-Label Phase II Study of Decitabine in Patients With Low- or Intermediate-Risk Myelodysplastic Syndromes
GARCIA-MANERO, Guillermo, JABBOUR, Elias, NADEEM, Ahmed, KASSALOW, Laurent, KANTARJIAN, Hagop, BORTHAKUR, Gautam, FADERL, Stefan, ESTROV, Zeev, HUI YANG, MADDIPOTI, Sirisha, GODLEY, Lucy A, GABRAIL, Nashat, BERDEJA, Jesus G
Published in Journal of clinical oncology (10.07.2013)
Published in Journal of clinical oncology (10.07.2013)
Get full text
Journal Article
Pomalidomide/Daratumumab/Dexamethasone in Relapsed or Refractory Multiple Myeloma: Final Overall Survival From MM-014
Bahlis, Nizar J., Samaras, Christy, Reece, Donna, Sebag, Michael, Matous, Jeffrey, Berdeja, Jesús G., Shustik, Jesse, Schiller, Gary J., Ganguly, Siddhartha, Song, Kevin, Seet, Christopher S., Acosta-Rivera, Mirelis, Bar, Michael, Quick, Donald, Fonseca, Gustavo, Liu, Hongjuan, Gentili, Christian, Singh, Pavit, Siegel, David
Published in Clinical lymphoma, myeloma and leukemia (08.08.2024)
Published in Clinical lymphoma, myeloma and leukemia (08.08.2024)
Get full text
Journal Article
A phase 1 trial of the Fc-engineered CD19 antibody XmAb5574 (MOR00208) demonstrates safety and preliminary efficacy in relapsed CLL
Woyach, Jennifer A., Awan, Farrukh, Flinn, Ian W., Berdeja, Jesus G., Wiley, Elizabeth, Mansoor, Sharmeen, Huang, Ying, Lozanski, Gerard, Foster, Paul A., Byrd, John C.
Published in Blood (04.12.2014)
Published in Blood (04.12.2014)
Get full text
Journal Article
Phase I/II study of the combination of panobinostat and carfilzomib in patients with relapsed/refractory multiple myeloma
Berdeja, Jesus G, Hart, Lowell L, Mace, Joseph R, Arrowsmith, Edward R, Essell, James H, Owera, Rami S, Hainsworth, John D, Flinn, Ian W
Published in Haematologica (Roma) (01.05.2015)
Published in Haematologica (Roma) (01.05.2015)
Get full text
Journal Article